Suchergebnisse - "Ivermectin"

PubPharm (537)

1

A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir/Ivermectin/Niclosamide in mild-to-moderate COVID-19 adult patients (FINCOV)

enthalten in: Journal of infection and public health | 2024

von Siripongboonsitti, T. | Tawinprai, K. | Avirutnan, P. | +2

2

Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Mikamo, H. | Takahashi, S. | Yamagishi, Y. | +17

3

Ivermectin for COVID-19 in adults in the community (PRINCIPLE) : An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

enthalten in: The Journal of infection | 2024

von Hayward, G. | Yu, L. | Little, P. | +23

4

Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies : a double-blinded randomized controlled trial

enthalten in: The British journal of dermatology | 2024

von Meyersburg, D. | Hoellwerth, M. | Brandlmaier, M. | +4

CommentIn: Br J Dermatol. 2024 Jan 17;:. - PMID 38234049

5

Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin : results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia

enthalten in: Parasites & vectors | 2024

von Kanza, E. | Nyathirombo, A. | Larbelee, J. | +17

6

Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia : a randomised, double-blind, non-inferiority, phase 2b/3 trial

enthalten in: The Lancet. Infectious diseases | 2024

von Sprecher, V. | Hofmann, D. | Savathdy, V. | +7

7

Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults - a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial

enthalten in: EBioMedicine | 2023

von Ekoka Mbassi, D. | Mombo-Ngoma, G. | Held, J. | +14

8

Efficacy and Safety of Moxidectin-Albendazole and Ivermectin-Albendazole Combination Therapy Compared to Albendazole Monotherapy in Adolescents and Adults Infected with Trichuris trichiura : A Randomized, Controlled Superiority Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Sprecher, V. | Coulibaly, J. | Hürlimann, E. | +2

9

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT) : a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2023

von Bramante, C. | Buse, J. | Liebovitz, D. | +106

CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1096-1097. - PMID 37302405

10

Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon : A randomized controlled assessor blinded clinical trial

enthalten in: PLoS neglected tropical diseases | 2023

von Zoleko-Manego, R. | Kreuzmair, R. | Veletzky, L. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[54]